Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2019-06-20Clinical Trial Update: Study of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive [Phase 2]
A Phase 2 clinical trial update evaluating daratumumab in multiple myeloma patients who are >VGPR/MRD-positive.
-
CLINICAL_TRIALS research · 2019-02-12Clinical Trial Update: Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers [Phase 2]
This clinical trial update describes a Phase 2 study evaluating donor lymphocyte infusion after stem cell transplant for hematologic cancers…
-
CLINICAL_TRIALS research · 2018-06-19Clinical Trial Update: The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd) [Phase 3]
Phase 3 clinical trial investigating ixazomib in autologous stem cell transplant for relapsed multiple myeloma. Recruitment is ongoing.
-
CLINICAL_TRIALS research · 2018-06-18Clinical Trial Update: Study of BCMA CAR-T in Multiple Myeloma [EARLY_Phase 1]
An early-phase study of BCMA-targeted CAR-T cell therapy for relapsed and refractory multiple myeloma; status is currently unknown.
-
CLINICAL_TRIALS research · 2018-06-14Clinical Trial Update: WB-EMS and Nutrition in Patients With Hematological Malignancies [NA]
A trial update describing the evaluation of whole-body electromyostimulation (WB-EMS) with nutrition in patients with hematologic malignanci…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2018-06-11Clinical Trial Update: Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients [Phase 3]
A Phase 3 clinical trial update evaluating a multi-agent combination including thalidomide, lenalidomide, carfilzomib, bortezomib, and vorin…
-
CLINICAL_TRIALS research · 2018-06-07Clinical Trial Update: Daratumumab, Thalidomide and Dexamethasone in Relapse and/or Refractory Myeloma [Phase 2]
Phase 2 clinical trial evaluating the combination of daratumumab, thalidomide, and dexamethasone in relapsed and/or refractory multiple myel…
-
CLINICAL_TRIALS research · 2018-06-06Clinical Trial Update: Non -Interventional Study-Palliative Therapy of Multiple Myeloma With a Combination of Lenalidomide and Dexamethasone
Update on a completed non-interventional study evaluating palliative therapy in multiple myeloma using a combination of lenalidomide and dex…
-
CLINICAL_TRIALS research · 2018-05-11Clinical Trial Update: Use Lay Language. HA Score to Identify Myeloma Patients Who Could Benefit From HDACi Treatment
The update describes a method using an HA Score to identify patients with recurrent or refractory multiple myeloma who may benefit from hist…
-
CLINICAL_TRIALS research · 2018-05-04Clinical Trial Update: Modified Bortezomib-based Combination Therapy for Multiple Myeloma [Phase 4]
A Phase 4 clinical trial update on a modified bortezomib-based combination therapy for multiple myeloma, with current status not disclosed.
-
CLINICAL_TRIALS research · 2018-04-25Clinical Trial Update: Protocol to Obtain Blood and Bone Marrow Samples for Myeloma Research
This clinical trial update describes a protocol to collect blood and bone marrow samples for multiple myeloma research; the study status is …
-
CLINICAL_TRIALS research · 2018-02-28Clinical Trial Update: Comprehensive Frailty Assessment
This update notes the completion of a study evaluating Comprehensive Frailty Assessment in patients with multiple myeloma.
-
CLINICAL_TRIALS research · 2017-12-06Clinical Trial Update: Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion) [Phase 1, Phase 2]
Phase 1/2 study investigating Antiminor Histocompatibility Complex (MiHA) T cells in patients with relapsed hematologic malignancies after m…
-
CLINICAL_TRIALS research · 2017-12-04Clinical Trial Update: A Study to Collect and Evaluate the Safety and Efficacy Information of Korean Multiple Myeloma Patients Treated With REVLIMID®, After Approval of Marketing Authorization for New Drug in Korea
A completed post-approval study in Korea collecting safety and efficacy data for multiple myeloma patients treated with REVLIMID (lenalidomi…
-
CLINICAL_TRIALS research · 2017-11-06Clinical Trial Update: Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) Versus Pomalidomide-Dexamethasone (PD) in Relapse or Refractory Myeloma [Phase 3]
Phase 3 trial comparing pomalidomide-cyclophosphamide-dexamethasone (PCD) versus pomalidomide-dexamethasone (PD) in relapse or refractory mu…
-
CLINICAL_TRIALS research · 2017-11-06Clinical Trial Update: Carfilzomib Thalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating a combination of carfilzomib, thalidomide, and dexamethasone in relapsed and/or refractory multiple myelom…
-
CLINICAL_TRIALS research · 2017-10-17Clinical Trial Update: Lonquek for Autologous Stem Cell Mobilization [Phase 1, Phase 2]
Clinical trial update for Lonquek in autologous stem cell mobilization across lymphoma and multiple myeloma (Phase 1/Phase 2).
-
CLINICAL_TRIALS research · 2017-10-11Clinical Trial Update: Role of CX3CR1-expressing Cells in Hematologic Malignancy
A clinical trial update examining the role of CX3CR1-expressing cells in hematologic malignancies, including Diffuse Large B-Cell Lymphoma a…
-
CLINICAL_TRIALS research · 2017-08-10Clinical Trial Update: Low Dose Plerixafor Plus G-CSF in Mobilizing Stem Cells for Autologous Peripheral Blood Transplantation [Phase 2]
A Phase 2 trial is evaluating low-dose plerixafor plus G-CSF to mobilize stem cells for autologous peripheral blood transplantation in lymph…
-
CLINICAL_TRIALS research · 2017-07-13Clinical Trial Update: Study of Risk Factors and Genetic Association With Bortezomib-induced Peripheral Neuropathy in Multiple Myeloma
This clinical trial update examines risk factors and genetic associations for peripheral neuropathy caused by bortezomib in people with mult…
-
CLINICAL_TRIALS research · 2017-06-27Clinical Trial Update: Collection of Patient-Reported Symptoms and Performance Status Via the Internet [NA]
This is a completed clinical trial update describing online collection of patient-reported symptoms and performance status across multiple c…
-
CLINICAL_TRIALS research · 2017-05-19Clinical Trial Update: Study of DNA Samples From Patients With Multiple Myeloma
An update on a study collecting DNA samples from patients with multiple myeloma, noting that the study status is completed.
-
CLINICAL_TRIALS research · 2017-05-17Clinical Trial Update: Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide
This update reports on a completed clinical study examining blood samples from patients with multiple myeloma and plasma cell neoplasms who …
-
CLINICAL_TRIALS research · 2017-05-09Clinical Trial Update: Blood Samples From Patients on a Clinical Trial to CINV During HSCT
This is an update on a clinical trial involving collection of blood samples from patients undergoing chemotherapy-induced nausea and vomitin…
-
CLINICAL_TRIALS research · 2017-05-02Clinical Trial Update: Carfilzomib Multiple Myeloma Expanded Access Protocol for Patients With Relapsed and Refractory Disease
Amgen's expanded access protocol for carfilzomib in relapsed and refractory multiple myeloma has been updated, with the drug noted as approv…